Open in app
Sign inGet started
Our investment in Vivodyne and its vision to make fewer drugs fail

Our investment in Vivodyne and its vision to make fewer drugs fail

Recent years have seen breakthrough therapeutic success ushered in by new and emergent drug modalities. Since 2017 eight fundamentally new…
Go to the profile of Caleb Appleton
Caleb Appleton
At the forefront of biology: Our investment in Juvena Therapeutics

At the forefront of biology: Our investment in Juvena Therapeutics

There are certain fields where human understanding remains limited, even naive. In biology, the ramifications of this are stark. While…
Go to the profile of Ben Hemani
Ben Hemani
The Biofrontier: Expanded Human Health

The Biofrontier: Expanded Human Health

“Human and planetary health” has emerged as common-speak in the venture world, referring to innovation that prolongs human health-span…
Go to the profile of Ari Wright
Ari Wright
About Bison VenturesLatest StoriesArchiveAbout MediumTermsPrivacyTeams